Живи долго! Научный подход к долгой молодости и здоровью - Майкл Грегер

5336

Farokhnia M, Shafiee Sabet M, Iranpour N, et al. Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer’s disease: a double-blind randomized clinical trial. Hum Psychopharmacol. 2014;29(4):351–9. https://pubmed.ncbi.nlm.nih.gov/25163440/

5337

Hausenblas HA, Heekin K, Mutchie HL, Anton S. A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes. J Integr Med. 2015;13(4):231–40. https://pubmed.ncbi.nlm.nih.gov/26165367/

5338

Ayati Z, Yang G, Ayati MH, Emami SA, Chang D. Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials. BMC Complement Med Ther. 2020;20(1):333. https://pubmed.ncbi.nlm.nih.gov/33167948/

5339

Tóth B, Hegyi P, Lantos T, et al. The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis. Planta Med. 2019;85(1):24–31. https://pubmed.ncbi.nlm.nih.gov/30036891/

5340

Tabeshpour J, Sobhani F, Sadjadi SA, et al. A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression. Phytomedicine. 2017;36:145–52. https://pubmed.ncbi.nlm.nih.gov/29157808/

5341

Finley JW, Gao S. A perspective on Crocus sativus L. (saffron) constituent crocin: a potent water-soluble antioxidant and potential therapy for Alzheimer’s disease. J Agric Food Chem. 2017;65(5):1005–20. https://pubmed.ncbi.nlm.nih.gov/28098452/

5342

World Health Organization. WHO Monographs on Selected Medicinal Plants. Vol 3. World Health Organization; 2001. https://apps.who.int/iris/handle/10665/42052

5343

Block BR, Albanese SG, Hume AL. Online promotion of “brain health” supplements. Sr Care Pharm. 2021;36(10):489–92. https://pubmed.ncbi.nlm.nih.gov/34593090/

5344

Goodwill AM, Szoeke C. A systematic review and meta-analysis of the effect of low vitamin D on cognition. J Am Geriatr Soc. 2017;65(10):2161–8. https://pubmed.ncbi.nlm.nih.gov/28758188/

5345

Kalra A, Teixeira AL, Diniz BS. Association of vitamin D levels with incident all-cause dementia in longitudinal observational studies: a systematic review and meta-analysis. J Prev Alzheimers Dis. 2020;7(1):14–20. https://pubmed.ncbi.nlm.nih.gov/32010921/

5346

Orces C, Lorenzo C, Guarneros JE. The prevalence and determinants of vitamin D inadequacy among U.S. older adults: National Health and Nutrition Examination Survey 2007–2014. Cureus. 2019;11(8):e5300. https://pubmed.ncbi.nlm.nih.gov/31579639/

5347

Riaz S, Malcangio M, Miller M, Tomlinson DR. A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia. 1999;42(11):1308–13. https://pubmed.ncbi.nlm.nih.gov/10550414/

5348

Durk MR, Han K, Chow ECY, et al. 1a,25-Dihydroxyvitamin D3 reduces cerebral amyloid-ß accumulation and improves cognition in mouse models of Alzheimer’s disease. J Neurosci. 2014;34(21):7091–101. https://pubmed.ncbi.nlm.nih.gov/24849345/

5349

Hu J, Jia J, Zhang Y, Miao R, Huo X, Ma F. Effects of vitamin D3 supplementation on cognition and blood lipids: a 12-month randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2018;89(12):1341–7. https://pubmed.ncbi.nlm.nih.gov/30279212/

5350

Jia J, Hu J, Huo X, Miao R, Zhang Y, Ma F. Effects of vitamin D supplementation on cognitive function and blood Aß-related biomarkers in older adults with Alzheimer’s disease: a randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2019;90(12):1347–52. https://pubmed.ncbi.nlm.nih.gov/31296588/

5351

Castle M, Fiedler N, Pop LC, et al. Three doses of vitamin D and cognitive outcomes in older women: a double-blind randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2020;75(5):835–42. https://pubmed.ncbi.nlm.nih.gov/30951148/

5352

Schietzel S, Fischer K, Brugger P, et al. Effect of 2000 IU compared with 800 IU vitamin D on cognitive performance among adults age 60 years and older: a randomized controlled trial. Am J Clin Nutr. 2019;110(1):246–53. https://pubmed.ncbi.nlm.nih.gov/31152541/

5353

Pettersen JA. Does high dose vitamin D supplementation enhance cognition?: a randomized trial in healthy adults. Exp Gerontol. 2017;90:90–7. https://pubmed.ncbi.nlm.nih.gov/28167237/

5354

Dysken MW, Sano M, Asthana S, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA Cooperative Randomized Trial. JAMA. 2014;311(1):33–44. https://pubmed.ncbi.nlm.nih.gov/24381967/

5355

Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med. 1997;336(17):1216–22. https://pubmed.ncbi.nlm.nih.gov/9110909/

5356

Lloret A, Badía MC, Mora NJ, Pallardó FV, Alonso MD, Viña J. Vitamin E paradox in Alzheimer’s disease: it does not prevent loss of cognition and may even be detrimental. J Alzheimers Dis. 2009;17(1):143–9. https://pubmed.ncbi.nlm.nih.gov/19494439/

5357

Yaffe K, Clemons TE, McBee WL, Lindblad AS. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology. 2004;63(9):1705–7. https://pubmed.ncbi.nlm.nih.gov/15534261/

5358

Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):23–33. https://pubmed.ncbi.nlm.nih.gov/12114036/

5359

Grodstein F, O’Brien J, Kang JH, et al. Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med. 2013;159(12):806–14. https://pubmed.ncbi.nlm.nih.gov/24490265/

5360

Maylor EA, Simpson EEA, Secker DL, et al. Effects of zinc supplementation on cognitive function in healthy middle-aged and older adults: the ZENITH study. Br J Nutr. 2006;96(4):752–60. https://pubmed.ncbi.nlm.nih.gov/17010236/

5361

Yaffe K, Clemons TE, McBee WL, Lindblad AS. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology. 2004;63(9):1705–7. https://pubmed.ncbi.nlm.nih.gov/15534261/

5362

Kern J, Kern S, Blennow K, et al. Calcium supplementation and risk of dementia in women with cerebrovascular disease. Neurology. 2016;87(16):1674–80. https://pubmed.ncbi.nlm.nih.gov/27534711/

5363

Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 2006;580(13):2994–3005. https://pubmed.ncbi.nlm.nih.gov/16697371/

5364

Rutjes AWS, Denton DA, Di Nisio M, et al. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and